Related references
Note: Only part of the references are listed.The Clinical Conundrum of Cannabis: Current Practices and Recommendations for Transplant Clinicians: An Opinion of the Immunology/Transplantation PRN of the American College of Clinical Pharmacy
Jennifer Melaragno et al.
TRANSPLANTATION (2021)
Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics
Jesse D. Schold et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients
Lu Chen et al.
XENOBIOTICA (2020)
Robotic kidney transplantation in the obese patient: 10-year experience from a single center
Ivo G. Tzvetanov et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Obesity, transplantation, and bariatric surgery: An evolving solution for a growing epidemic
Tayyab S. Diwan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
A Multidisciplinary Technique for Concurrent Panniculectomy-Living Donor Renal Transplantation
Ledibabari M. Ngaage et al.
ANNALS OF PLASTIC SURGERY (2020)
Bariatric Surgery Outcomes in Patients with Prior Solid Organ Transplantation: an MBSAQIP Analysis
Alexander M. Fagenson et al.
OBESITY SURGERY (2020)
A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation
Thiyagarajan Thangavelu et al.
DIABETES THERAPY (2020)
Effects of Obesity on Postoperative Complications and Graft Survival After Kidney Transplantation
Marie Fellmann et al.
TRANSPLANTATION PROCEEDINGS (2020)
Cardiac transplantation: indications, eligibility and current outcomes
Sai Kiran Bhagra et al.
HEART (2019)
Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice
Jennifer C. Lai et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Medical Contraindications to Transplant Listing in the USA: A Survey of Adult and Pediatric Heart, Kidney, Liver, and Lung Programs
Anji Wall et al.
WORLD JOURNAL OF SURGERY (2019)
Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review
Megan E. Harrison et al.
APPETITE (2019)
Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery
Adam J. Lucas et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Delayed Sleeve Gastrectomy Following Liver Transplantation: A 5-Year Experience
Mackenzie C. Morris et al.
LIVER TRANSPLANTATION (2019)
The utility of robotic assisted pancreas transplants - a single center retrospective study
Mario Spaggiari et al.
TRANSPLANT INTERNATIONAL (2019)
Panniculectomy at the time of living donor renal transplantation: An 8-year experience
Ledibabari M. Ngaage et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Bariatric surgery in solid organ transplant patients: Long-term follow-up results of outcome, safety, and effect on immunosuppression
Renana Yemini et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters
Cornelis Smit et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss A PCORnet Cohort Study
David Arterburn et al.
ANNALS OF INTERNAL MEDICINE (2018)
RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice
Lorry Hachon et al.
OBESITY SURGERY (2017)
The effect of morbid obesity on morphine glucuronidation
Celia Lloret-Linares et al.
PHARMACOLOGICAL RESEARCH (2017)
Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective study
Michelle Willicombe et al.
TRANSPLANT INTERNATIONAL (2017)
Obesity and kidney disease: Hidden consequences of the epidemic
C. P. Kovesdy et al.
PHYSIOLOGY INTERNATIONAL (2017)
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide
Sjoerd de Hoogd et al.
CLINICAL PHARMACOKINETICS (2017)
Pharmacokinetic and pharmacogenetic analysis of immunosuppressive agents after laparoscopic sleeve gastrectomy
Tayyab S. Diwan et al.
CLINICAL TRANSPLANTATION (2017)
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose
Louise M. Andrews et al.
TRANSPLANTATION DIRECT (2017)
Obesity and inflammation: the linking mechanism and the complications
Mohammed S. Ellulu et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen
Anne van Rongen et al.
CLINICAL PHARMACOKINETICS (2016)
Effect of the Obesity Epidemic on Kidney Transplantation: Obesity Is Independent of Diabetes as a Risk Factor for Adverse Renal Transplant Outcomes
Jennifer M. Kwan et al.
PLOS ONE (2016)
Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation
Jad Khoraki et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Drug Disposition in Obesity: Toward Evidence-Based Dosing
Catherijne A. J. Knibbe et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
Shi Sum Poon et al.
JOURNAL OF CROHNS & COLITIS (2015)
A consensus document for the selection of lung transplant candidates: 2014-An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
David Weill et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2015)
Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients
Catherine A. Pennington et al.
PHARMACOTHERAPY (2015)
Optimizing Pancreas Transplantation Outcomes in Obese Recipients
Jerome M. Laurence et al.
TRANSPLANTATION (2015)
Bariatric Surgery and Liver Transplantation: a Systematic Review a New Frontier for Bariatric Surgery
Andrea Lazzati et al.
OBESITY SURGERY (2015)
Laparoscopic Sleeve Gastrectomy as a Weight Reduction Strategy in Obese Patients After Kidney Transplantation
I. Golomb et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Michael D. Jensen et al.
CIRCULATION (2014)
New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
Mohamad Mohty et al.
DRUGS (2014)
Current status of bariatric surgery in Japan and effectiveness in obesity and diabetes
Akira Sasaki et al.
JOURNAL OF GASTROENTEROLOGY (2014)
A Novel and Personalized Rehabilitation Program for Obese Kidney Transplant Recipients
I. Tzvetanov et al.
TRANSPLANTATION PROCEEDINGS (2014)
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review
Katja Trobec et al.
PLOS ONE (2013)
Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation
Matthew Y. C. Lin et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2013)
Controlled-Dose Versus Fixed-Dose Mycophenolate Mofetil for Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Xianding Wang et al.
TRANSPLANTATION (2013)
Presence of Apolipoprotein C-III Defines a High Density Lipoprotein Subtype that is not Inversely Associated with Incident Coronary Events
Majken K. Jensen et al.
CIRCULATION (2013)
Obesity and Kidney Transplant Candidates: How Big Is Too Big for Transplantation?
Krista L. Lentine et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation
P. Stratta et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Deficiency of Carboxylesterase 1/Esterase-x Results in Obesity, Hepatic Steatosis, and Hyperlipidemia
Ariel D. Quiroga et al.
HEPATOLOGY (2012)
Impact of Small Variations in the Delivered Dose of Rabbit Antithymocyte Induction Therapy in Kidney Transplantation With Early Corticosteroid Withdrawal
Demetra S. Tsapepas et al.
TRANSPLANTATION (2012)
Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
Seung Seok Han et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2012)
Implications of Obesity for Drug Therapy: Limitations and Challenges
R. Jain et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
On the Accuracy of Estimation of Basic Pharmacokinetic Parameters by the Traditional Noncompartmental Equations and the Prediction of the Steady-State Volume of Distribution in Obese Patients Based Upon Data Derived from Normal Subjects
Leonid M. Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Obesity in Renal Transplantation: The Role of Induction Therapy on Long-Term Outcomes
S. Patel et al.
TRANSPLANTATION PROCEEDINGS (2011)
Pitfalls in defining and quantifying cachexia
Vickie E. Baracos
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
Nonrandomized Trial of Weight Loss With Orlistat, Nutrition Education, Diet, and Exercise in Obese Patients With CKD: 2-Year Follow-up
Helen L. MacLaughlin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
The Effect of Body Mass Index on Survival Following Heart Transplantation Do Outcomes Support Consensus Guidelines?
Mark J. Russo et al.
ANNALS OF SURGERY (2010)
Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation
Dirk R. J. Kuypers et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Significant Differences Between Crohn's Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients
Martin H. Holtmann et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Involvement of Carboxylesterase 1 and 2 in the Hydrolysis of Mycophenolate Mofetil
Nobuhiro Fujiyama et al.
DRUG METABOLISM AND DISPOSITION (2010)
The impact of recipient body mass index on survival after lung transplantation
Jeremiah G. Allen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Mycophenolic Acid Exposure in High- and Low-Weight Renal Transplant Patients After Dosing With Mycophenolate Mofetil in the Opticept Trial
Bruce Kaplan et al.
THERAPEUTIC DRUG MONITORING (2010)
Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients
Christian Noel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Liver Transplantation at the Extremes of the Body Mass Index
Andre A. S. Dick et al.
LIVER TRANSPLANTATION (2009)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Accuracy of body mass index in diagnosing obesity in the adult general population
A. Romero-Corral et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study
Christin C. Rogers et al.
CLINICAL TRANSPLANTATION (2008)
Is a standard fixed dose of mycophenolate mofetil ideal for all patients?
Wai-Ping Yau et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Effects of body mass index at transplant on outcomes of kidney transplantation
Sean H. Chang et al.
TRANSPLANTATION (2007)
Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer
Rony Dev et al.
CANCER (2007)
Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial
David Cassiman et al.
TRANSPLANT INTERNATIONAL (2006)
Rabbit antithymocyte globulin versus basiliximab in renal transplantation
Daniel C. Brennan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effect of obesity and overweight on cyclosporine blood levels and renal functions in renal adolescent recipients
B Kasap et al.
TRANSPLANTATION PROCEEDINGS (2006)
Orlistat (Xenical)-induced subacute liver failure
PH Thurairajah et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis
DN Homnick et al.
PEDIATRIC PULMONOLOGY (2005)
The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation
S Satoh et al.
TRANSPLANTATION PROCEEDINGS (2005)
High initial blood levels of tacrolimus in overweight renal transplant recipients
E Rodrigo et al.
TRANSPLANTATION PROCEEDINGS (2005)
Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome
H Trout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Cyproheptadine is an effective appetite stimulant in cystic fibrosis
DN Homnick et al.
PEDIATRIC PULMONOLOGY (2004)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Demographics and trends in overweight and obesity in patients at time of kidney transplantation
AN Friedman et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Drug interaction in a renal transplant patient: cyclosporin-neoral and Orlistat
S Evans et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine
T Kraus et al.
PHARMACOPSYCHIATRY (2002)
Massive hepatocullular necrosis: Was it caused by orlistat?
G Lau et al.
MEDICINE SCIENCE AND THE LAW (2002)
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients
VR Peddi et al.
TRANSPLANTATION (2002)
Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis
V Eubanks et al.
JOURNAL OF PEDIATRICS (2002)
Reduction in blood cyclosporine concentration by orlistat in two renal transplant patients
P Errasti et al.
TRANSPLANTATION PROCEEDINGS (2002)
The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death
HU Meier-Kriesche et al.
TRANSPLANTATION (2002)
Study of the cyclosporine concentration at 2 hours in stable renal transplant patients and relation to body mass index
L Hortal et al.
TRANSPLANTATION PROCEEDINGS (2001)
Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity
A Duchini et al.
TRANSPLANTATION (2001)
Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - a population pharmacokinetic study
S Mouly et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Co-administration of orlistat and cyclosporine in a heart transplant recipient
C Le Beller et al.
TRANSPLANTATION (2000)
Orlistat decreases the plasma level of cyclosporine and may be responsible for the development of acute rejection episodes
B Schnetzler et al.
TRANSPLANTATION (2000)
Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis
V Marchand et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2000)
Share Paper
